Dinner Short Course, Organized by Cambridge Healthtech Institute (CHI):
Structure- and Dynamics-Based Design Strategies
Tuesday, May 20 | 6:00-9:00 pm
Westin Boston Waterfront, Boston, MA
This course will reveal design strategies that led to drugs currently in the
clinic and on the market. An emphasis will be made on the exploitation of
the bioactive ligand conformations using combinations of NMR, X-ray,
calculations and SAR. Rational design and the implications of other
properties will be addressed which include atropisomer chirality, drug
self-aggregation and ADMET. This course will be held prior to the start of
the 14th annual "Structure-Based Drug Design (SBDD)" conference being held
on May 21-22.
Instructors:
Steven LaPlante, Ph.D., Founder & CEO, NMX Research & Solutions; Adjunct
Professor, Institut National de la Recherche Scientifique (INRS)
Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group
Detailed Agenda:
6:00 Dinner Served
6:15 Strategies for Drug Design Starting from Peptides, HTS Hits and
Small-Molecule Fragments
Steven LaPlante, Ph.D., Founder & CEO, NMX Research & Solutions; Adjunct
Professor, Institut National de la Recherche Scientifique (INRS)
7:15 Coffee Break
7:45 Designing Inhibitors with MOE Structure-Based Drug Design Tools
Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group
8:45 Q&A with Speakers
9:00 Close of Course.
How to Register:
Web: <https://chidb.com/register/2014/sbd/reg.asp>
https://chidb.com/register/2014/sbd/reg.asp
Call: 781-972-5400
Email: <mailto:reg from healthtech.com> reg from healthtech.com
For details and to register for the SBDD conference, visit
<http://www.healthtech.com/structure-based-drug-design>
www.healthtech.com/structure-based-drug-design.
For questions, contact:
James Prudhomme
Senior Marketing Manager
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
Direct: 781-972-5486
<mailto:jprudhomme from healthtech.com> jprudhomme from healthtech.com